title: Quadruple immunosuppression in renal allografts--the Auckland experience.
abstract: Recipients of live related and first cadaveric renal allografts were retrospectively reviewed before and after institution of a standardized regimen incorporating greater immunosuppression, (by the addition of antilymphocyte preparations). The two review groups were comparable with 11 live related and 27 first cadaver grafts in each. Despite a small advantage in terms of graft survival and diminished rejection, this was at the expense of septic morbidity. The implications of this are discussed.
authors.affiliation: Department of Surgery, Auckland Hospital.
authors.forename: D
authors.initials: D
authors.lastname: Verran
authors.forename: S
authors.initials: S
authors.lastname: Munn
authors.forename: P
authors.initials: P
authors.lastname: Doak
authors.forename: L
authors.initials: L
authors.lastname: Williams
authors.forename: J
authors.initials: J
authors.lastname: Collins
authors.forename: W
authors.initials: W
authors.lastname: Lee
mesh_terms: D000961:Antilymphocyte Serum / Q000008:administration & dosage; D002102:Cadaver; D006084:Graft Rejection; D006085:Graft Survival; D006801:Humans; D007165:Immunosuppression Therapy / Q000379:methods*; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D016030:Kidney Transplantation / Q000401:mortality; D009520:New Zealand; D012189:Retrospective Studies; D014019:Tissue Donors
chemical_list: D000961:Antilymphocyte Serum; D007166:Immunosuppressive Agents